AcelRx Pharmaceuticals, Inc. (ACRX)
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in AcelRx Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $76 for a total return of roughly -99.24%. All prices are adjusted for splits and dividends.
Compare to other instruments
Return
AcelRx Pharmaceuticals, Inc. had a return of -69.47% year-to-date (YTD) and -89.10% in the last 12 months. Over the past 10 years, AcelRx Pharmaceuticals, Inc. had an annualized return of -39.64%, while the S&P 500 had an annualized return of 9.77%, indicating that AcelRx Pharmaceuticals, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -55.48% | -1.87% |
| Year-To-Date | -69.47% | 4.25% |
| 6 months | -86.58% | 2.64% |
| 1 year | -89.10% | -10.31% |
| 5 years (annualized) | -56.01% | 7.81% |
| 10 years (annualized) | -39.64% | 9.77% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -11.50% | -29.00% | ||||||||||
| 2022 | -29.15% | -36.84% | -9.47% | -5.44% |
Dividend History
AcelRx Pharmaceuticals, Inc. doesn't pay dividends
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the AcelRx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the AcelRx Pharmaceuticals, Inc. is 99.78%, recorded on Mar 20, 2023. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.78% | Jul 23, 2013 | 2431 | Mar 20, 2023 | — | — | — |
| -60% | Jun 1, 2011 | 135 | Dec 30, 2011 | 218 | Nov 26, 2012 | 353 |
| -33.63% | Feb 14, 2011 | 46 | Apr 19, 2011 | 27 | May 27, 2011 | 73 |
| -33.4% | Nov 27, 2012 | 8 | Dec 6, 2012 | 29 | Jan 18, 2013 | 37 |
| -21.97% | Feb 14, 2013 | 23 | Mar 19, 2013 | 16 | Apr 11, 2013 | 39 |
| -15.9% | Jun 12, 2013 | 10 | Jun 25, 2013 | 5 | Jul 2, 2013 | 15 |
| -10.99% | May 17, 2013 | 3 | May 21, 2013 | 1 | May 22, 2013 | 4 |
| -9.84% | Jan 23, 2013 | 12 | Feb 7, 2013 | 4 | Feb 13, 2013 | 16 |
| -9.76% | Apr 24, 2013 | 6 | May 1, 2013 | 4 | May 7, 2013 | 10 |
| -9.29% | Apr 15, 2013 | 3 | Apr 17, 2013 | 4 | Apr 23, 2013 | 7 |
Volatility Chart
Current AcelRx Pharmaceuticals, Inc. volatility is 195.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.